PN placement: two rows, both leaf "Regulator of the lysosomal v-ATPase proton pump": (1) ALP|Pre-initiation autophagy signaling|mTORC1 upstream|Nutrient sensing|... and (2) ALP|Lysosomal catabolism|Regulation of lysosomal environment|Lysosomal acidification|.... PN-node mapping: leaves = mapped, GO:0060590 ATPase regulator activity (new_to_goa); plus type-node GO:0007042 lysosomal lumen acidification (already_in_goa_exact).
Consistency: Deep research/notes, review, and PN agree: ATP6AP1/Ac45 is an accessory V0 assembly-hub/regulatory subunit (PMID:33065002, PMID:27231034). Review adds GO:0060590 (action NEW, IC) and ACCEPTs GO:0007042 — exactly matching both PN projections. Verified: GO:0060590 absent from goa.tsv (genuinely new); GO:0007042 present (NAS, ComplexPortal) confirming "already_in_goa_exact". No contradictions.
PN story / NEW pressure: PN asserts a regulator MF not previously in GOA. Review correctly converts the legacy GO:0140677 (molecular function activator activity) → GO:0060590 and adds it as NEW core MF. GO:0060590 is a real term and the conservative right target (vs. uninformative protein binding, six of which are MARK_AS_OVER_ANNOTATED). ADD GO:0060590 — implemented.
Mapping strategy: Gene meaningfully supports the leaf mapping (it is the archetypal "regulator of lysosomal V-ATPase"). Projected GO:0060590 is neither broader nor narrower than the review's chosen core MF — they coincide. GO:0007042 type-node projection matches existing GOA. Mapping is appropriate; no change.
Evidence alignment: PN cites one title (Translational Neurodegeneration V-ATPase/lysosomal acidification review); review's supporting PMIDs (33065002 structural, 27231034 disease/localization, 22053050 mTORC1) are stronger and fully cover the claims. Minor: PN's single secondary-review citation is thinner than the review's primary set, but no conflict.
Verdict: CONSISTENT — NEW GO:0060590 (verified real) appropriately added; PN leaf and acidification mappings align with review. No edits required.